Skip to main content

Table 1 Comparison of the baseline data between the two groups (\(\overline{\user2{X}}\) ± S)

From: Can preoperative ureteral stents reduce the incidence of ureteral stricture after radiotherapy in patients with cervical cancer?

Clinical features

Stents group

Control group

T/Z/χ.2

P

(n = 26)

(n = 29)

Age (years)

51.38 ± 8.75

51.69 ± 11.64

0.109

0.914

Surgery type (n, %)

  

2.988

0.224

Radical hysterectomy

0 (0.0%)

1 (3.4%)

  

Radical hysterectomy + pelvic lymphadenectomy

4 (15.4%)

9 (31.0%)

  

Radical hysterectomy + pelvic and para-aortic lymphadenectomy

22 (84.6%)

19 (65.5%)

  

FIGO clinical stage (n, %)

  

0.906

0.636

Stage I

14 (53.8)

18 (62.1)

  

Stage II

7 (26.9)

8 (27.6)

  

Stage III

5 (19.2)

3 (10.3)

  

Pathological type (n, %)

  

1.257

0.533

Carcinoma, squamous cell

23 (88.5)

25 (86.2)

  

Adenocarcinoma

2 (7.7)

1 (3.4)

  

Carcinoma, denosquamous

1 (3.8)

3 (10.3)

  

Radiotherapy time (days)

38.50 ± 7.49

35.48 ± 5.08

1.765

0.083

Creatinine (µmol L−1)

62.18 ± 6.45

58.28 ± 7.88

1.995

0.051

Urea nitrogen (mmol L−1)

4.00 ± 1.13

4.10 ± 1.05

0.342

0.734

Glomerular filtration rate (ml min−1)

91.13 ± 13.70

99.05 ± 15.88

1.971

0.054

Urinalysis specific gravity

1.01 ± 0.01

1.01 ± 0.01

0.865

0.391